Drybench Patent.
IBRUTINIB, NDA 210563
The patents and exclusivities FDA's Orange Book lists for NDA 210563 as captured on 14 October 2026, each date named by its rule and its rows, and the rows of FDA's Paragraph IV list that give this NDA's number, as captured on 17 October 2026. Listed protection is a range of dates, never one date.
FDA capture · review pending. Each row is shown as captured from FDA's Orange Book files and Paragraph IV list. Dates are FDA's own; spreadsheet day numbers are shown as dates, and a cell that cannot be read as one date is shown as written and left out of the range. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. A Paragraph IV row is placed here only by the number in its RLD/NDA cell; nothing is joined by name. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.
- Orange Book captured
- 14 October 2026
- Paragraph IV list captured
- 17 October 2026
- Last checked
- 30 October 2026
- Data-branch commit
- dadcab56563716abea6c5e31a5e1970080c778ef
Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.
Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.
Listed protection
Listed dates run from 24 Aug 2025 to 3 Sep 2036, each by its own rule; no one date stands for this product.
- Earliest listed date
- 24 Aug 2025NPP exclusivityRule R3 · Products 001, 002, 003, 004 · exclusivity.txt lines 889, 893, 897, 901
- Latest listed date
- 3 Sep 2036US 9,655,857 with pediatric exclusivity, as listedRule R2 · Products 001, 002, 003, 004 · patent.txt lines 11,679, 11,783, 11,887, 11,996
- Latest substance patent
- 30 Apr 2034US 9,296,753 with pediatric exclusivity, as listedRule R2 · Products 001, 002, 003, 004 · patent.txt lines 11,677, 11,781, 11,885, 11,994
- Latest listed patent
- 3 Sep 2036US 9,655,857 with pediatric exclusivity, as listedRule R2 · Products 001, 002, 003, 004 · patent.txt lines 11,679, 11,783, 11,887, 11,996
- Latest exclusivity
- 24 Feb 2030PED exclusivityRule R3 · Products 001, 002, 003, 004 · exclusivity.txt lines 892, 896, 900, 904
224 use-code patents, blocking the coded use only
Products
Each product number FDA lists under NDA 210563, as listed. The sections below name products by these numbers.
Product 001 · IMBRUVICA
- Dosage form; route
- TABLET;ORAL
- Strength
- 140MG
- Approval date as listed
- 16 Feb 2018
- Type as listed
- RX
- Applicant as listed
- PHARMACYCLICS LLC
Product 002 · IMBRUVICA
- Dosage form; route
- TABLET;ORAL
- Strength
- 280MG
- Approval date as listed
- 16 Feb 2018
- Type as listed
- RX
- Applicant as listed
- PHARMACYCLICS LLC
Product 003 · IMBRUVICA
- Dosage form; route
- TABLET;ORAL
- Strength
- 420MG
- Approval date as listed
- 16 Feb 2018
- Type as listed
- RX
- Applicant as listed
- PHARMACYCLICS LLC
Product 004 · IMBRUVICA
- Dosage form; route
- TABLET;ORAL
- Strength
- 560MG
- Approval date as listed
- 16 Feb 2018
- Type as listed
- DISCN
- Applicant as listed
- PHARMACYCLICS LLC
Listed patents
Every patent the FDA lists for this product, as the application holder submitted it, with its flags. The FDA does not verify listings.
120 entries from 424 rows as listed; rows merge only where every cell shown is the same, each with its product numbers.
US 7,514,444, substance and product patent
patent.txt lines 11,631, 11,735, 11,839, 11,941- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 8,476,284, use patent
patent.txt lines 11,635, 11,739, 11,843, 11,946- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 8,476,284, use patent
patent.txt lines 11,636, 11,740, 11,844, 11,947- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 8,476,284, use patent
patent.txt lines 11,637, 11,741, 11,845, 11,949- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 8,476,284, use patent
patent.txt line 11,945- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 8,476,284, use patent
patent.txt line 11,948- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1947
- Product numbers
- 004
US 8,497,277, use patent
patent.txt lines 11,644, 11,748, 11,852- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-3422
- Product numbers
- 001, 002, 003
US 8,497,277, use patent
patent.txt lines 11,639, 11,743, 11,847, 11,952- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 8,497,277, use patent
patent.txt lines 11,640, 11,744, 11,848, 11,953- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 8,497,277, use patent
patent.txt lines 11,641, 11,745, 11,849, 11,954- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 8,497,277, use patent
patent.txt lines 11,642, 11,746, 11,850, 11,956- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 8,497,277, use patent
patent.txt lines 11,643, 11,747, 11,851, 11,957- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 8,497,277, use patent
patent.txt line 11,951- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 8,497,277, use patent
patent.txt line 11,955- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1947
- Product numbers
- 004
US 8,697,711, substance and product patent
patent.txt lines 11,652, 11,756, 11,860, 11,965- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 8,703,780, use patent
patent.txt lines 11,654, 11,758, 11,862, 11,967- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 8,703,780, use patent
patent.txt lines 11,655, 11,759, 11,863, 11,968- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 8,735,403, substance and product patent
patent.txt lines 11,657, 11,761, 11,865, 11,970- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 8,754,091, product patent
patent.txt lines 11,659, 11,763, 11,867, 11,974- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt lines 11,661, 11,765, 11,869, 11,977- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt lines 11,662, 11,766, 11,870, 11,978- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt lines 11,663, 11,767, 11,871, 11,979- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt lines 11,664, 11,768, 11,872, 11,981- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt lines 11,665, 11,769, 11,873, 11,982- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 8,952,015, use patent
patent.txt line 11,976- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 8,952,015, use patent
patent.txt line 11,980- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- use code U-1947
- Product numbers
- 004
US 8,957,079, substance and product patent
patent.txt lines 11,667, 11,771, 11,875, 11,984- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 9,181,257, substance patent
patent.txt lines 11,676, 11,780, 11,884, 11,993- Expiry as listed
- 28 Dec 2026
- Rule
- R1
- Flags
- substance
- Product numbers
- 001, 002, 003, 004
US 8,563,563, use patent
patent.txt lines 11,646, 11,750, 11,854, 11,959- Expiry as listed
- 26 Apr 2027
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 8,563,563, use patent
patent.txt lines 11,647, 11,751, 11,855, 11,960- Expiry as listed
- 26 Apr 2027
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 8,563,563, use patent
patent.txt lines 11,648, 11,752, 11,856, 11,961- Expiry as listed
- 26 Apr 2027
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 8,563,563, use patent
patent.txt lines 11,649, 11,753, 11,857, 11,962- Expiry as listed
- 26 Apr 2027
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 8,563,563, use patent
patent.txt lines 11,650, 11,754, 11,858, 11,963- Expiry as listed
- 26 Apr 2027
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 7,514,444 with pediatric exclusivity, as listed
patent.txt lines 11,630, 11,734, 11,838, 11,940- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,476,284 with pediatric exclusivity, as listed
patent.txt lines 11,634, 11,738, 11,842, 11,944- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,497,277 with pediatric exclusivity, as listed
patent.txt lines 11,638, 11,742, 11,846, 11,950- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,697,711 with pediatric exclusivity, as listed
patent.txt lines 11,651, 11,755, 11,859, 11,964- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,703,780 with pediatric exclusivity, as listed
patent.txt lines 11,653, 11,757, 11,861, 11,966- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,735,403 with pediatric exclusivity, as listed
patent.txt lines 11,656, 11,760, 11,864, 11,969- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,754,091 with pediatric exclusivity, as listed
patent.txt lines 11,658, 11,762, 11,866, 11,973- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,952,015 with pediatric exclusivity, as listed
patent.txt lines 11,660, 11,764, 11,868, 11,975- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,957,079 with pediatric exclusivity, as listed
patent.txt lines 11,666, 11,770, 11,874, 11,983- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,181,257 with pediatric exclusivity, as listed
patent.txt lines 11,675, 11,779, 11,883, 11,992- Expiry as listed
- 28 Jun 2027
- Rule
- R2
- Flags
- substance · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,563,563 with pediatric exclusivity, as listed
patent.txt lines 11,645, 11,749, 11,853, 11,958- Expiry as listed
- 26 Oct 2027
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,008,309, substance and product patent
patent.txt lines 11,633, 11,737, 11,841, 11,943- Expiry as listed
- 13 Nov 2027
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 8,008,309 with pediatric exclusivity, as listed
patent.txt lines 11,632, 11,736, 11,840, 11,942- Expiry as listed
- 13 May 2028
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,004,746, use patent
patent.txt lines 11,588, 11,694, 11,798, 11,902- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1684
- Product numbers
- 001, 002, 003, 004
US 10,004,746, use patent
patent.txt lines 11,589, 11,695, 11,799, 11,903- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 10,004,746, use patent
patent.txt lines 11,590, 11,696, 11,800, 11,904- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 10,004,746, use patent
patent.txt lines 11,591, 11,697, 11,801, 11,905- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 10,016,435, use patent
patent.txt lines 11,595, 11,701, 11,805, 11,909- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,611, 11,717, 11,821- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-3422
- Product numbers
- 001, 002, 003
US 10,478,439, use patent
patent.txt lines 11,605, 11,711, 11,815, 11,920- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,606, 11,712, 11,816, 11,921- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1684
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,607, 11,713, 11,817, 11,922- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,608, 11,714, 11,818, 11,924- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,609, 11,715, 11,819, 11,925- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt lines 11,610, 11,716, 11,820, 11,926- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2665
- Product numbers
- 001, 002, 003, 004
US 10,478,439, use patent
patent.txt line 11,919- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 10,478,439, use patent
patent.txt line 11,923- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1947
- Product numbers
- 004
US 10,653,696, use patent
patent.txt line 11,928- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 10,751,342, use patent
patent.txt lines 11,615, 11,721, 11,825, 11,932- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 10,751,342, use patent
patent.txt lines 11,616, 11,722, 11,826, 11,933- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 10,751,342, use patent
patent.txt lines 11,617, 11,723, 11,827, 11,934- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2943
- Product numbers
- 001, 002, 003, 004
US 10,751,342, use patent
patent.txt lines 11,618, 11,724, 11,828, 11,935- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2944
- Product numbers
- 001, 002, 003, 004
US 11,672,803, use patent
patent.txt lines 11,625, 11,729, 11,833- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1684
- Product numbers
- 001, 002, 003
US 11,672,803, use patent
patent.txt lines 11,626, 11,730, 11,834- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003
US 11,672,803, use patent
patent.txt lines 11,627, 11,731, 11,835- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003
US 11,672,803, use patent
patent.txt lines 11,628, 11,732, 11,836- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003
US 8,754,090, use patent
patent.txt line 11,972- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1456
- Product numbers
- 004
US 8,999,999, use patent
patent.txt lines 11,669, 11,773, 11,877, 11,986- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 8,999,999, use patent
patent.txt lines 11,670, 11,774, 11,878, 11,987- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1946
- Product numbers
- 001, 002, 003, 004
US 8,999,999, use patent
patent.txt lines 11,671, 11,775, 11,879, 11,988- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2241
- Product numbers
- 001, 002, 003, 004
US 8,999,999, use patent
patent.txt lines 11,672, 11,776, 11,880, 11,989- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 9,125,889, use patent
patent.txt lines 11,674, 11,778, 11,882, 11,991- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1650
- Product numbers
- 001, 002, 003, 004
US 9,801,881, use patent
patent.txt lines 11,688, 11,792, 11,896, 12,004- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1491
- Product numbers
- 001, 002, 003, 004
US 9,801,881, use patent
patent.txt lines 11,689, 11,793, 11,897, 12,005- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2242
- Product numbers
- 001, 002, 003, 004
US 9,801,883, use patent
patent.txt lines 11,691, 11,795, 11,899, 12,007- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2159
- Product numbers
- 001, 002, 003, 004
US 9,801,883, use patent
patent.txt lines 11,692, 11,796, 11,900, 12,008- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-2243
- Product numbers
- 001, 002, 003, 004
US 9,814,721, use patent
patent.txt line 12,010- Expiry as listed
- 3 Jun 2031
- Rule
- R1
- Flags
- use code U-1947
- Product numbers
- 004
US 10,004,746 with pediatric exclusivity, as listed
patent.txt lines 11,587, 11,693, 11,797, 11,901- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,016,435 with pediatric exclusivity, as listed
patent.txt lines 11,594, 11,700, 11,804, 11,908- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,478,439 with pediatric exclusivity, as listed
patent.txt lines 11,604, 11,710, 11,814, 11,918- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,653,696 with pediatric exclusivity, as listed
patent.txt line 11,927- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
US 10,751,342 with pediatric exclusivity, as listed
patent.txt lines 11,614, 11,720, 11,824, 11,931- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 8,754,090 with pediatric exclusivity, as listed
patent.txt line 11,971- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
US 8,999,999 with pediatric exclusivity, as listed
patent.txt lines 11,668, 11,772, 11,876, 11,985- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,125,889 with pediatric exclusivity, as listed
patent.txt lines 11,673, 11,777, 11,881, 11,990- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,801,881 with pediatric exclusivity, as listed
patent.txt lines 11,687, 11,791, 11,895, 12,003- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,801,883 with pediatric exclusivity, as listed
patent.txt lines 11,690, 11,794, 11,898, 12,006- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,814,721 with pediatric exclusivity, as listed
patent.txt line 12,009- Expiry as listed
- 3 Dec 2031
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
US 10,106,548, substance and product patent
patent.txt lines 11,597, 11,703, 11,807, 11,911- Expiry as listed
- 3 Jun 2033
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 10,125,140, substance and product patent
patent.txt lines 11,599, 11,705, 11,809, 11,913- Expiry as listed
- 3 Jun 2033
- Rule
- R1
- Flags
- substance · product
- Product numbers
- 001, 002, 003, 004
US 10,752,634, product patent
patent.txt line 11,620- Expiry as listed
- 3 Jun 2033
- Rule
- R1
- Flags
- product
- Product numbers
- 001
US 10,961,251, product patent
patent.txt lines 11,624, 11,728, 11,832, 11,939- Expiry as listed
- 3 Jun 2033
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 9,725,455, substance patent
patent.txt lines 11,682, 11,786, 11,890, 11,999- Expiry as listed
- 3 Jun 2033
- Rule
- R1
- Flags
- substance
- Product numbers
- 001, 002, 003, 004
US 9,296,753, substance patent
patent.txt lines 11,678, 11,782, 11,886, 11,995- Expiry as listed
- 30 Oct 2033
- Rule
- R1
- Flags
- substance
- Product numbers
- 001, 002, 003, 004
US 10,106,548 with pediatric exclusivity, as listed
patent.txt lines 11,596, 11,702, 11,806, 11,910- Expiry as listed
- 3 Dec 2033
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,125,140 with pediatric exclusivity, as listed
patent.txt lines 11,598, 11,704, 11,808, 11,912- Expiry as listed
- 3 Dec 2033
- Rule
- R2
- Flags
- substance · product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,752,634 with pediatric exclusivity, as listed
patent.txt line 11,619- Expiry as listed
- 3 Dec 2033
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
US 10,961,251 with pediatric exclusivity, as listed
patent.txt lines 11,623, 11,727, 11,831, 11,938- Expiry as listed
- 3 Dec 2033
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,725,455 with pediatric exclusivity, as listed
patent.txt lines 11,681, 11,785, 11,889, 11,998- Expiry as listed
- 3 Dec 2033
- Rule
- R2
- Flags
- substance · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,296,753 with pediatric exclusivity, as listed
patent.txt lines 11,677, 11,781, 11,885, 11,994- Expiry as listed
- 30 Apr 2034
- Rule
- R2
- Flags
- substance · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,463,668, use patent
patent.txt lines 11,603, 11,709, 11,813, 11,917- Expiry as listed
- 24 Oct 2034
- Rule
- R1
- Flags
- use code U-2654
- Product numbers
- 001, 002, 003, 004
US 10,695,350, use patent
patent.txt lines 11,613, 11,719, 11,823, 11,930- Expiry as listed
- 24 Oct 2034
- Rule
- R1
- Flags
- use code U-2846
- Product numbers
- 001, 002, 003, 004
US 9,795,604, use patent
patent.txt lines 11,686, 11,790, 11,894- Expiry as listed
- 24 Oct 2034
- Rule
- R1
- Flags
- use code U-3422
- Product numbers
- 001, 002, 003
US 9,795,604, use patent
patent.txt lines 11,684, 11,788, 11,892, 12,001- Expiry as listed
- 24 Oct 2034
- Rule
- R1
- Flags
- use code U-2969
- Product numbers
- 001, 002, 003, 004
US 9,795,604, use patent
patent.txt lines 11,685, 11,789, 11,893, 12,002- Expiry as listed
- 24 Oct 2034
- Rule
- R1
- Flags
- use code U-2970
- Product numbers
- 001, 002, 003, 004
US 10,463,668 with pediatric exclusivity, as listed
patent.txt lines 11,602, 11,708, 11,812, 11,916- Expiry as listed
- 24 Apr 2035
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,695,350 with pediatric exclusivity, as listed
patent.txt lines 11,612, 11,718, 11,822, 11,929- Expiry as listed
- 24 Apr 2035
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,795,604 with pediatric exclusivity, as listed
patent.txt lines 11,683, 11,787, 11,891, 12,000- Expiry as listed
- 24 Apr 2035
- Rule
- R2
- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,010,507, product patent
patent.txt lines 11,593, 11,699, 11,803, 11,907- Expiry as listed
- 3 Mar 2036
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 10,213,386, product patent
patent.txt lines 11,601, 11,707, 11,811, 11,915- Expiry as listed
- 3 Mar 2036
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 10,828,259, product patent
patent.txt lines 11,622, 11,726, 11,830, 11,937- Expiry as listed
- 3 Mar 2036
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 12,551,448, product patent
patent.txt lines 11,629, 11,733, 11,837- Expiry as listed
- 3 Mar 2036
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003
US 9,655,857, product patent
patent.txt lines 11,680, 11,784, 11,888, 11,997- Expiry as listed
- 3 Mar 2036
- Rule
- R1
- Flags
- product
- Product numbers
- 001, 002, 003, 004
US 10,010,507 with pediatric exclusivity, as listed
patent.txt lines 11,592, 11,698, 11,802, 11,906- Expiry as listed
- 3 Sep 2036
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,213,386 with pediatric exclusivity, as listed
patent.txt lines 11,600, 11,706, 11,810, 11,914- Expiry as listed
- 3 Sep 2036
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 10,828,259 with pediatric exclusivity, as listed
patent.txt lines 11,621, 11,725, 11,829, 11,936- Expiry as listed
- 3 Sep 2036
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
US 9,655,857 with pediatric exclusivity, as listed
patent.txt lines 11,679, 11,783, 11,887, 11,996- Expiry as listed
- 3 Sep 2036
- Rule
- R2
- Flags
- product · pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
Listed exclusivities
Each exclusivity FDA lists for NDA 210563, with its code, FDA's definition of the code where the store's code list gives one, and its date as listed.
NPP exclusivity
exclusivity.txt lines 889, 893, 897, 901- Date
- 24 Aug 2025
- Rule
- R3
- Definition
- New patient population (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
PED exclusivity
exclusivity.txt lines 891, 895, 899, 903- Date
- 24 Feb 2026
- Rule
- R3
- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
ODE-405 exclusivity
exclusivity.txt lines 890, 894, 898, 902- Date
- 24 Aug 2029
- Rule
- R3
- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
PED exclusivity
exclusivity.txt lines 892, 896, 900, 904- Date
- 24 Feb 2030
- Rule
- R3
- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
Paragraph IV list rows giving NDA 210563
The rows of FDA's Paragraph IV certifications list as captured on 17 October 2026 whose RLD/NDA cell gives NDA 210563, each cell as listed.
FDA's Paragraph IV list names no patent number, so it does not say which of the patents on this page an applicant certified against.
The list gives the last qualifying patent's expiry without pediatric exclusivity; in the app's Patents view, the Orange Book lists any *PED period as a separate row with its own date. The two dates describe different things. A blank cell is one FDA left blank in its list. Dates are FDA's own; the last qualifying patent expiry is not recomputed from the Orange Book.
Rows whose RLD/NDA cell we could not read as exactly one NDA number are kept apart on the list page; some may concern this product.
Rows on FDA's Paragraph IV list whose RLD/NDA cell gives NDA 210563
Ibrutinib · Tablets · 140 mg
RLD/NDA as listed: Imbruvica 210563- First PIV submission
- 5 Nov 2018
- ANDAs
- 1
- 180-day status
- blank
- Decision posted
- blank
- First applicant approval
- blank
- First marketing
- blank
- Last qualifying patent expiry (as listed by FDA)
- 3 Mar 2036
Ibrutinib · Tablets · 560 mg
RLD/NDA as listed: Imbruvica 210563- First PIV submission
- 5 Nov 2018
- ANDAs
- 1
- 180-day status
- Extinguished
- Decision posted
- 8 Jul 2024
- First applicant approval
- blank
- First marketing
- blank
- Last qualifying patent expiry (as listed by FDA)
- 3 Mar 2036
Ibrutinib · Tablets · 280 mg and 420 mg
RLD/NDA as listed: Imbruvica 210563- First PIV submission
- 14 Dec 2018
- ANDAs
- 1
- 180-day status
- blank
- Decision posted
- blank
- First applicant approval
- blank
- First marketing
- blank
- Last qualifying patent expiry (as listed by FDA)
- 3 Mar 2036
Notes from the trace
- R6 tentative approvals: not in the Orange Book data files as captured; the Drugs@FDA join is a later ruling.
Patents vs FDA exclusivityHow to read the Orange Book data filesParagraph IV certificationWhat changed, by week